Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial
Status:
Completed
Trial end date:
2021-05-30
Target enrollment:
Participant gender:
Summary
Pragmatic randomized clinical trial of patients admitted to the hospital with confirmed
COVID-19 infection and elevated D-Dimer.
Randomization 1:1 - Group 1 will undergo a routine full anticoagulation (oral or parenteral
when needed) strategy; and group 2 will receive usual standard of care with prophylactic
anticoagulation
Phase:
Phase 4
Details
Lead Sponsor:
Brazilian Clinical Research Institute
Collaborators:
Beneficência Portuguesa de São Paulo Brazilian Research In Intensive Care Network Hospital Alemão Oswaldo Cruz Hospital do Coracao Hospital Israelita Albert Einstein Hospital Moinhos de Vento Hospital Sirio-Libanes